Aerobic exercise should last 30 minutes, excluding warm-up and cool-down.As people with diabetes know, you should do at least 30 minutes of aerobic exercise per day, at least 5 days a week — that is, at least 150 minutes per week.This 30-minute period does not count from the time you leave home to when you […]
People with Diabetes Can Choose Their Favorite Exercises Based on Calorie Expenditure
People with diabetes have many exercise options, and each type of exercise corresponds to a different intensity. For the same duration, calorie expenditure varies across individuals and exercise types.To provide a practical reference for exercise, the China Guidelines for Exercise Therapy in Diabetes recommend that patients with diabetes should aim to expend 300 kcal per […]
Benefits of Exercise for People with Diabetes Go Beyond Blood Glucose Control
Exercise for people with diabetes not only helps control blood glucose but also provides other health benefits:① Promotes weight loss and helps maintain an ideal body weight;② Lowers LDL cholesterol and triglycerides, helping regulate blood lipids;③ Enhances cardiopulmonary endurance;④ Increases muscle and vascular elasticity, helping to lower blood pressure;⑤ Improves blood circulation;⑥ Boosts self-confidence and […]
7 Benefits of Waking Up Early for People with Diabetes
The Huffington Post in the United States once published an article listing seven health benefits of waking up early. In the editor’s opinion, besides these benefits, early rising gives busy people with diabetes extra time for exercise. Try going to bed and waking up early—it helps you stick to exercise and better control your blood […]
Walking Reduces Cardiovascular Disease Risk in Patients with Diabetes
“Diabetes is equivalent to cardiovascular disease.” Patients with diabetes, especially elderly patients, are familiar with this statement. According to international studies, the risk of myocardial infarction in people with diabetes alone is the same as in those with coronary heart disease alone. In fact, 70%–80% of patients with diabetes eventually die from end‑point events such […]
How to Exercise When Diabetes Coexists with Comorbidities
Diabetes seldom occurs alone. Besides elevated blood glucose, patients with diabetes often have comorbidities such as hypertension and dyslipidemia. If diabetes and its comorbidities are poorly controlled in the long term, various complications may develop, including diabetic peripheral neuropathy, diabetic kidney disease, diabetic peripheral vascular disease, diabetic foot ulcers, diabetic eye disease, and diabetic cardiovascular […]
Updated Meta-Analysis: Effects of Different Weight-Loss Medications on Fat Distribution
As one of the most prevalent health problems worldwide, obesity imposes substantial public health and economic burdens, which have attracted increasing attention from patients, regulatory agencies, and biopharmaceutical companies.Currently, research and development efforts are actively exploring weight‑loss medications targeting different pathways in the pathophysiology of obesity.Although various anti‑obesity or glucose‑lowering agents have been widely used […]
Banting Science Achievement Award Recipient: Development of Amyloid Inhibitors Promising to Slow T2DM Progression
At the 85th Scientific Sessions of the American Diabetes Association (ADA 2025), the presentation of the Banting Medal for Scientific Achievement was undoubtedly one of the most anticipated highlights. As the highest scientific honor of the ADA, this award commemorates Dr. Frederick Banting—the medical scientist, physician, and Nobel laureate who played a pivotal role in […]
Elevated Fatty Liver Index (FLI) Is a Strong Independent Predictor of Sudden Cardiac Arrest (SCA) in Adults Without Cardiovascular Disease (CVD)
A recent study published in Heart Rhythm demonstrated that an elevated Fatty Liver Index (FLI) is a strong independent predictor of sudden cardiac arrest (SCA) in adults without baseline cardiovascular disease (CVD), with a gradual increase in SCA risk corresponding to higher FLI levels. These findings underscore the importance of incorporating metabolic dysfunction-associated steatotic liver […]
MASLD Increases All-Cause Mortality Risk in Type 2 Diabetes
Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasingly becoming one of the most prevalent chronic liver diseases worldwide. Although the disease directly impairs liver function, causing abnormal fat accumulation and hepatocellular injury, its most life-threatening threat often does not originate from liver lesions themselves. In fact, MASLD more commonly significantly elevates patients’ all-cause mortality risk […]